Form D · Pharmaceuticals

Cydan, LLC

Cambridge, MA · CIK 0001573851

Offering snapshot reported Oct 2, 2013 · SEC filing

Reported sold
$6.6M
Offering amount: $26.3M
Investors reported
6
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 28, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.3M$6.6MApr 11, 2013: $3,966,336.00Apr 11, 2013Oct 2, 2013: $6,601,336.00Oct 2, 2013

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$3,966,336 → $6,601,336
  • Reported investors3 → 6

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 2, 2013Amendment$6,601,336$2,635,000vs Apr 11, 20136SEC filing
Apr 11, 2013Initial$3,966,336No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-194829

Source: Form D, filed Oct 2, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Christoph M. Adams Executive
Cristina Csimma Director, Executive
Barbara Dalton Director
Deborah Geraghty Executive
James Mc Arthur Executive
David Mott Director
Sara Nayeem Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
300 Technology Square 8th Floor
Cambridge, MA, 02139